Home
  >  
Section 79
  >  
Chapter 78,991

Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation

Guillet, C.; Steinmann, S.; Lang, C.; Maul, J.-T.; Schmid-Grendelmeier, P.

Journal of Allergy and Clinical Immunology. in Practice 9(3): 1393-1395.E1

2021


ISSN/ISBN: 2213-2201
PMID: 33096266
DOI: 10.1016/j.jaip.2020.10.020
Accession: 078990554

Download citation:  
Text
  |  
BibTeX
  |  
RIS

PDF emailed within 0-6 h: $19.90